All PlansAdministrativeMedium impact
Voluntary nationwide recall: Atovaquone (Bionpharma – September)
UPMC Health Plan·Infectious Disease, Oncology, Hematology +2 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Bionpharma Inc. has issued a voluntary recall of Atovaquone Oral Suspension lot 2310083 due to bacterial contamination that can cause life-threatening complications. Healthcare providers should immediately identify patients who received this lot and discontinue use of the contaminated medication.
Action Required
Immediately: Clinical staff must identify all patients who received Atovaquone Oral Suspension lot 2310083 and contact them to discontinue use and return the medication. Providers should document the recall notification in patient charts and arrange alternative treatment if needed. Contact Bionpharma at 1-888-235-2466 for recall coordination.